Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer
Molecules · 2024
DOI: 10.3390/molecules29225382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Doaa Mohamed Elroby Ali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt. Hauptthemen laut MEDLINE: Ciprofloxacin, Apoptosis, Antineoplastic Agents, Molecular Docking Simulation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dean of Science and Research at King Khalid University, Dean of Science and Research at King Khalid University via the Large Group.
Abstract (Originalsprache)
The current study has yielded promising results in the evaluation of a new ciprofloxacin-chalcone hybrid (CP derivative) for its anticancer activity as potential Topoisomerases (Topo) I and II inhibitors. The in vitro results showed that the CP derivative significantly suppressed the growth of HCT-116 and LOX IMVI cells, with IC50 values of 5.0 μM and 1.3 μM, respectively, outperforming Staurosporine, which had IC50 values of 8.4 μM and 1.6 μM, respectively. Flow cytometry analysis revealed that the new CP derivative triggered apoptosis and cell cycle arrest at the G2/M phase, associated with the up-regulation of pro-apoptotic genes (Bax and Caspase 9) and downregulation of the anti-apoptotic gene (Bcl-2). Further investigations showed that the CP derivative inhibited Topo I and II enzymes, as expected molecular targets; docking studies further supported its dual inhibitory action on Topo I and II. These findings suggest that the ciprofloxacin-chalcone hybrid could be a promising lead compound for developing new anticancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, New Valley University, New Valley 72511, Egypt.
- Institute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Kaiserstrasse 12, 76131 Karlsruhe, Germany.
- Chemistry Department, Faculty of Science, King Khalid University, Abha 64734, Saudi Arabia.
- Department of Pharmacology, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
ORCID-Profile: Stefan Bräse, Abdullah Alkhammash, Hamada Hashem
Förderung
- Dean of Science and Research at King Khalid University
- Dean of Science and Research at King Khalid University via the Large Group
Zitieren
APA
Ali, D. M. E., Aziz, H. A., Bräse, S., Al Bahir, A., Alkhammash, A., Abuo-Rahma, G. E. A., Elshamsy, A. M., Hashem, H., & Abdelmagid, W. M. (2024). Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer. Molecules. https://doi.org/10.3390/molecules29225382
Vancouver
Ali DME, Aziz HA, Bräse S, Al Bahir A, Alkhammash A, Abuo-Rahma GEA, et al. Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer. Molecules. 2024. doi:10.3390/molecules29225382
BibTeX
@article{Ali2024,
author = {Ali, Doaa Mohamed Elroby and Aziz, Hossameldin A and Bräse, Stefan and Al Bahir, Areej and Alkhammash, Abdullah and Abuo-Rahma, Gamal El-Din A and Elshamsy, Ali M and Hashem, Hamada and Abdelmagid, Walid M},
title = {Unveiling the Anticancer Potential of a New Ciprofloxacin-Chalcone Hybrid as an Inhibitor of Topoisomerases I & II and Apoptotic Inducer},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225382}
}
EUVIMED